- Global Pharma News & Resources

2018 World's Leading Generic Drug Companies: Mylan, Novartis, Pfizer, Sun Pharma & Teva - Capabilities, Goals and Strategies -

The "2018 World's Leading Generic Drug Companies: Capabilities, Goals and Strategies" report has been added to's offering.

This report is part of the Competitive Analysis Series to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors.

The report analyzes the following companies:

  • Mylan
  • Novartis
  • Pfizer
  • Sun Pharma
  • Teva

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs.

In the dynamic and fragmented Generic Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.

The report's objectives include:

  • To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

For more information about this report visit

View source version on

Editor Details

Last Updated: 19-Oct-2018